Advances
in phototheranostics revolutionized glioma intraoperative
fluorescence imaging and phototherapy. However, the lack of desired
active targeting agents for crossing the blood–brain barrier
(BBB) significantly compromises the theranostic efficacy. In this
study, biomimetic proteolipid nanoparticles (NPs) with U.S. Food and
Drug Administration (FDA)-approved indocyanine green (ICG) were constructed
to allow fluorescence imaging, tumor margin detection, and phototherapy
of orthotopic glioma in mice. By embedding glioma cell membrane proteins
into NPs, the obtained biomimetic ICG-loaded liposome (BLIPO-ICG)
NPs could cross BBB and actively reach glioma at the early stage thanks
to their specific binding to glioma cells due to their excellent homotypic
targeting and immune escaping characteristics. High accumulation in
the brain tumor with a signal to background ratio of 8.4 was obtained
at 12 h post-injection. At this time point, the glioma and its margin
were clearly visualized by near-infrared fluorescence imaging. Under
the imaging guidance, the glioma tissue could be completely removed
as a proof of concept. In addition, after NIR laser irradiation (1
W/cm2, 5 min), the photothermal effect exerted by BLIPO-ICG
NPs efficiently suppressed glioma cell proliferation with a 94.2%
tumor growth inhibition. No photothermal damages of normal brain tissue
and treatment-induced side effects were observed. These results suggest
that the biomimetic proteolipid NP is a promising phototheranostic
nanoplatform for brain-tumor-specific imaging and therapy.
Active-targeted cancer imaging and therapy of glioma has attracted much attention in theranostic nanomedicine. As a promising tumor-targeting ligand, holo-transferrin (holo-Tf) has been applied for enhancing delivery of nanotheranostics. However, holo-Tf-based nanoassemblies for active targeting mediated multimodal imaging and therapeutics have not been previously reported. Here, we develop a one-step method for the preparation of holo-Tf-indocyanine green (holo-Tf-ICG) nanoassemblies for fluorescence (FL) and photoacoustic (PA) dual-modal imaging and photothermal therapy (PTT) of glioma. The nanoassemblies are formed by hydrophobic interaction and hydrogen bonds between holo-Tf and ICG, which exhibit excellent active tumor-targeting and high biocompability. The brain tumor with highly expressed Tf receptor can be clearly observed with holo-Tf-ICG nanoassemblies base on FL and PA dual-modal imaging in subcutaneous and orthotopic glioma models. Under the near-infrared laser irradiation, the holo-Tf-ICG nanoassemblies accumulated in tumor regions can efficiently convert laser energy into hyperthermia for tumor ablation. The novel theranostic nanoplatform holds great promise for precision diagnosis and treatment of glioma.
Targeting drug delivery remains a challenge in various disease treatment including cancer. The local drug deposit could be greatly enhanced by some external stimuli-responsive systems. Here we develop pluronic P123/F127 polymeric micelles (M) encapsulating curcumin (Cur) that are permeabilized directly by focused ultrasound, in which ultrasound triggers drug release. Tumor preferential accumulation and site-specific sonochemotherapy were then evaluated. Cur-loaded P123/F127 mixed micelles (Cur-M) exhibited longer circulating time and increased cellular uptake compared to free Cur. With the assistance of focused ultrasound treatment, Cur-M showed tumor-targeting deposition in a time-dependent manner following systemic administration. This was due to enhanced permeabilization of tumor regions and increased penetration of Cur-M in irradiated tumor cells by ultrasound sonoporation. Furthermore, Cur-M self-assembly could be regulated by ultrasound irradiation. In vitro Cur release from mixed micelles was greatly dependent on ultrasound intensity but not on duration, suggesting the cavitational threshold was necessary to initiate subsequent sonochemotherapy. In vivo site-specific drug release was demonstrated in dual-tumor models, which showed spatial-temporal release of entrapped drugs following intratumoral injection. The sonoporation-assisted site-specific chemotherapy significantly inhibited tumor growth and the decrease in tumor weight was approximately 6.5-fold more than without exposure to ultrasound irradiation. In conclusion, the established ultrasound-guided nanomedicine targeting deposit and local release may represent a new strategy to improve chemotherapy efficiency.
The findings demonstrated that Ce6-mediated SPDT enhanced the antitumor efficacy on 4T1 cells compared with SDT and PDT alone, a Caspase-dependent apoptosis and loss of MMP, generation of ROS may be involved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.